CHC Healthcare Group
TWSE:4164
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/IC
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Valuation Scenarios
If EV/IC returns to its 3-Year Average (1), the stock would be worth NT$43.71 (50% upside from current price).
| Scenario | EV/IC Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.6 | NT$29.05 |
0%
|
| 3-Year Average | 1 | NT$43.71 |
+50%
|
| 5-Year Average | 0.9 | NT$40.31 |
+39%
|
| Industry Average | 1.5 | NT$67.5 |
+132%
|
| Country Average | 1.2 | NT$53.37 |
+84%
|
Forward EV/IC
Today’s price vs future invested capital
Peer Comparison
| Market Cap | EV/IC | P/E | ||||
|---|---|---|---|---|---|---|
| TW |
|
CHC Healthcare Group
TWSE:4164
|
5.7B TWD | 0.6 | 30.5 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
100.1B USD | 5 | 23.1 | |
| US |
|
Cencora Inc
NYSE:COR
|
59.1B USD | 3.2 | 36.4 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
59.5B USD | 3.2 | 36.6 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
46.1B USD | 3.2 | 27.7 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32.3B AUD | 4.8 | 35.5 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.4B CNY | 0.6 | 11.1 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.6B USD | 1.2 | 21.5 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.5B CNY | 2.1 | 20.6 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 4.7 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
57.6B HKD | 0 | 7.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.9 |
| Median | 1.2 |
| 70th Percentile | 1.8 |
| Max | 1 954.3 |
Other Multiples
CHC Healthcare Group
Glance View
CHC Healthcare Group engages in investment and the distribution, maintenance, and lease of radiation oncology, neuromedicine, imaging medicine, ophthalmology, and surgical instruments. The company is headquartered in Taipei City, Taipei. The company went IPO on 2011-10-18. The firm primarily involves in the agent distribution of radiation oncology, neurology, medical image and nuclear medical, as well as dental and ophthalmological equipment and instrument. The firm also offers related maintenance and leasing services, components and consumable materials and specialty consulting services. The firm deals with medical instrument with brands as Elekta, PTW, GE, Ashland, Megin, Leica, Hillrom, Sony, Ellex and Wexler, among others. The firm is also involved in the operation of pharmacy.
